
A new immunotherapy approach may very well pave the way to treating hepatitis B virus (HBV) — a major global health concern and the most common cause of liver cancer. Researchers from the University College London (UCL), with support from the University of Oxford, the Royal Free London NHS Trust, and Leiden University Medical Centre […]